enGenome at ESHG 2024 to present Corporate Satellite with guest from Twist Bioscience
Company will showcase its latest advancements at ESHG 2024, featuring a Corporate Satellite session with Twist Bioscience and an exciting iPhone giveaway.
20 May 2024

enGenome is thrilled to announce its participation in the European Society of Human Genetics (ESHG) 2024 Conference, taking place from June 1st to June 3rd in Berlin, Germany. This event is one of the most significant gatherings in the field of human genetics in Europe, and enGenome is excited to showcase its latest innovations and advancements.

Event Highlight: Corporate Satellite Session with Twist Bioscience

Mark your calendars for enGenome’s special Corporate Satellite session, where they will be collaborating with Twist Bioscience to present groundbreaking solutions in genomic variant interpretation.

What to Expect:

Section 1: VarChat – The First Generative AI Genomic Assistant
Speaker: Susanna Zucca, enGenome CSO
Discover VarChat, the first generative AI platform to rapidly retrieve and summarize scientific literature on human genomic variants. See how it can streamline research and clinical workflows.

Section 2: eVai Suggested Diagnosis – Award-Winning Variant Prioritization
Speaker: Ivan Limongelli, enGenome CTO
Learn about eVai, the award-winning variant interpreter for monogenic and digenic interpretation. Understand how eVai can enhance the accuracy and efficiency of genomic analysis.

Section 3: CNVs Detection Performance on Twist Panels
Speakers: Tina Han, Director of Applications & Business Development at Twist Bioscience, and Ivan Limongelli, enGenome CTO
Explore the performance of copy number variant (CNV) detection on Twist panels.

Exciting Giveaway!

As a special treat for those attending in person, there will be an iPhone giveaway during the session! 

Join enGenome at ESHG 2024 for an insightful session and do not forget to stop by booth #542.

For more information about the event and to register, visit the ESHG 2024 Conference website.

Press Contact: Giovana Herold -